TD Cowen analyst Ritu Baral reiterated a Buy rating on Opus Genetics (NASDAQ: IRD).The analyst commented: "High Conviction For Meaningful ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE